Clinical trials sponsored by Anhui Provincial Cancer Hospital

Phase breakdown

Conditions studied

Recruiting trials led by Anhui Provincial Cancer Hospital

• Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer (PULSE Study)
  NCT07744698 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC
  NCT07330596 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Tislelizumab Combined With Chemotherapy and Relayed Radiotherapy in First-line Treatment of ES-SCLC
  NCT06838208 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer
  NCT07195084 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Anhui Provincial Cancer Hospital recruiting for?

Anhui Provincial Cancer Hospital is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.